Data Science Lead, Katya Putintseva, presented at The Antibody Engineering & Therapeutics conference

12th December 2021

Data Science Lead, Katya Putintseva, explains how machine learning is directing LabGenius’ exploration of protein fitness landscapes to help find better protein therapeutics.



About LabGenius

Headquartered in London, LabGenius is a leading machine learning-driven protein engineering company. The company’s core technology platform, EVA™, enables the rapid discovery of novel therapeutic antibodies. LabGenius’ highly multidisciplinary team brings together the very best minds from the fields of computer science, robotic automation and synthetic biology.

For more information, please visit www.labgeni.us, or connect on Twitter and LinkedIn.

For more information, please contact:

Media enquiries:
Communications Lead
Lucy Shaw
press@labgeni.us

Business development:
Chief Operating Officer
Didier Landais
didier.landais@labgeni.us


EventsLabGenius